Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
A Phase 1 Open-label, Multicenter, First-in-human, Ascending Dose Trial Evaluating the Safety and Tolerability of a Lipid Nanoparticle Formulation of CRISPR-Guide RNA-Cas9 Nuclease (CTX310) for In Vivo Editing of the Angiopoietin-like 3 (ANGPTL3) Gene in Participants With Refractory Dyslipidemias
This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years of age with dyslipidemias that are ref…
CardiovascularMetabolic DiseaseDyslipidemias+7 more
Estimated
~$10 – $8,750
CRISPR Therapeutics AGNCT07491172
Phase 2
Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) Trial
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders (EMERALD) is a protocolized intervention based on American College of Cardiology/American…
Lipid DisorderHypercholesterolemiaCardiovascular Diseases+1 more
Estimated
~$10 – $6,250
Wake Forest University Health SciencesNCT06488105
Lipoprotein Functions in Healthy Individuals and Subjects With Lipid Disorders
This study looks at how lipoproteins, which are particles in the blood that transport cholesterol, influence heart and blood vessel health. Beyond just their l…
Lipid Disorders
Estimated
~$10 – $750
The Miriam HospitalNCT06747000